Cargando…

The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic relapsing-remitting immune-mediated disorder affecting the gut. It is common in Westernized regions and is increasing in incidence in developing countries. At a molecular level, intrinsic deficiencies in epithelial integrity, mucosal barrier function, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Connell, Lauren, Winter, Des C., Aherne, Carol M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925404/ https://www.ncbi.nlm.nih.gov/pubmed/33681101 http://dx.doi.org/10.3389/fped.2021.624045

Ejemplares similares

Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
por: Yoo, Jun-Hwan, et al.
Publicado: (2019)

Adalimumab in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2022)

Pancreatic Involvement in Pediatric Inflammatory Bowel Disease
por: Martín-de-Carpi, Javier, et al.
Publicado: (2017)

Advanced Understanding of Monogenic Inflammatory Bowel Disease
por: Nambu, Ryusuke, et al.
Publicado: (2021)

Inflammatory Bowel Disease: A Personalized Approach
por: Konidari, Anastasia, et al.
Publicado: (2021)

The epidemiology of inflammatory bowel disease: Clues to pathogenesis?
por: Borowitz, Stephen M.
Publicado: (2023)

Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
por: Schulte, L., et al.
Publicado: (2019)

Prevalence of Celiac Disease in Children and Adolescents With Inflammatory Bowel Disease
por: Eskander, Ayman, et al.
Publicado: (2020)

Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2020)

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020)

Pain and quality of life in youth with inflammatory bowel disease: the role of parent and youth perspectives on family functioning
por: Caes, Line, et al.
Publicado: (2019)

Inflammatory Bowel Disease in Children: Experience and Constraints in a Resource-limited Setting
por: Adeniyi, Oluwafunmilayo F, et al.
Publicado: (2020)

The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
por: Galgut, Bianca J., et al.
Publicado: (2018)

Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
por: Sun, Yue, et al.
Publicado: (2019)

Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease
por: Giannoudaki, Eirini, et al.
Publicado: (2021)

An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease
por: Shaoul, Ron, et al.
Publicado: (2021)

Linear Growth Impairment in Patients With Pediatric Inflammatory Bowel Disease
por: Isa, Hasan M, et al.
Publicado: (2022)

Biopsychosocial Correlates of Presence and Intensity of Pain in Adolescents With Inflammatory Bowel Disease
por: Murphy, Lexa K., et al.
Publicado: (2020)

Infantile Inflammatory Bowel Disease in a Three-Month-Old-Boy
por: Iida, Chie, et al.
Publicado: (2021)

Transition Readiness Into Adult Health Care in Children With Inflammatory Bowel Disease
por: Alsufyani, Hadeel A., et al.
Publicado: (2023)

Legius Syndrome and Inflammatory Bowel Disease: A Pediatric Case Report
por: Paixao, Filipa, et al.
Publicado: (2023)

Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
por: Klomberg, Renz C. W., et al.
Publicado: (2022)

The Clinical Spectrum of Inflammatory Bowel Disease Associated With Specific Genetic Syndromes: Two Novel Pediatric Cases and a Systematic Review
por: Gatti, Simona, et al.
Publicado: (2021)

A Review of the Use of Complementary and Alternative Medicines by Children with Inflammatory Bowel Disease
por: Day, Andrew S.
Publicado: (2013)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Infantile-onset inflammatory bowel disease has variable long-term outcomes
por: Krauthammer, Alex, et al.
Publicado: (2023)

Inflammatory Bowel Disease Infusion Therapy Adherence in a Rural Pediatric Population
por: Hernandez Garcia, Laura R, et al.
Publicado: (2023)

Pulmonary Manifestations of Inflammatory Bowel Disease in Children
por: Taylor, Mark A, et al.
Publicado: (2020)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Assessment of Knowledge Levels Following an Education Program for Parents of Children With Inflammatory Bowel Disease
por: Vernon-Roberts, Angharad, et al.
Publicado: (2020)

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence
por: Meredith, Joseph, et al.
Publicado: (2021)

Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy Experience
por: Sansotta, Naire, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
por: Bosa, Luca, et al.
Publicado: (2022)

New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease
por: Li, Qi-Qi, et al.
Publicado: (2022)

The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain
por: Isa, Hasan M, et al.
Publicado: (2023)

Organoid-based regenerative medicine for inflammatory bowel disease
por: Okamoto, Ryuichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pe3q3b2me2bgraee8khgm1ri10